Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Oxford Cancer Biomarkers Ltd.
DescriptionCompanion diagnostic biomarker test for HDAC inhibitor drugs
Molecular Target Histone deacetylase (HDAC)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPreclinical
Standard IndicationCancer, Diagnostic
Indication DetailsIdentify patients that respond to HDAC inhibitors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today